Has Nirav Shah, MD received payments from drug or device companies?

Yes. Drug and device makers reported $137,419 in general payments to Nirav Shah, MD across 280 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nirav Shah, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nirav Shah, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nirav Shah, MD

Pain Medicine · Skokie, ILNPI 1306282439

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $91,527 of the $137,419 with a category attached, or 66.6%. SPR Therapeutics, Inc accounts for 91.9% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $35,393, 7.2 times the $4,911 reported in 2019. Among pain medicine clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$137,419in general payments, 2019–2025

Across 280 payments — averaging $490.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

SPR Therapeutics, Inc$126K
Vertiflex, Inc.$3K
Stryker$2K
Nalu Medical, Inc.$1K
Abbott$1K
Vertos Medical, Inc.$945
plus $3K from 11 others

What the payments were for

Consulting fees$91,52767%
Speaking & faculty fees$820%
Travel & lodging$21,96416%
Food & beverage$23,80517%
Education$400%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
SPR Therapeutics, Inc	166	$126,331
Vertiflex, Inc.	12	$2,650
Stryker	4	$1,709
Nalu Medical, Inc.	15	$1,245
Abbott	18	$1,099
Vertos Medical, Inc.	9	$945
Biotronik NRO, Inc.	14	$854
Avanos Medical	11	$679
Relievant Medsystems, Inc.	6	$496
Medtronic(2 entities)	4	$320
Nevro Corp.	5	$309
Boston Scientific	3	$231
Pacira Pharmaceuticals Incorporated	3	$175
Saluda Medical Americas, Inc.	2	$154
Vertex	5	$131
Merck	2	$52
Astellas Pharma US Inc	1	$40

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SPRINT PNS System$124,357
Superion ISS$2,381
Intracept$1,109
mild Device Kit$749
Prospera$591
Nalu Neurostimulation System$546
Proclaim Family of SCS IPGs$420
Senza Spinal Cord Stimulation System$215
INTELLIS$149
S-Series SCS Leads$140
GENERATOR$119
Superion Indirect Decompression System$113
PROCLAIM$103
COOLIEF* COOLED RADIOFREQUENCY$101

How this compares

$137,419 in reported general payments places this provider in the 95th percentile of 233 pain medicine providers in Illinois.

See all pain medicine providers in Illinois →

Medicare billing

Part B allowed, 2024

$148,981

Medicare patients

510

Services billed

1,065

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Buprenorphine	32	$4,711
Celecoxib	176	$4,178
Duloxetine Hcl	236	$4,105
Baclofen	167	$2,258
Gabapentin	102	$1,190
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	23	$778
Nortriptyline Hcl	90	$592
Morphine Sulfate	13	$450
Morphine Sulfate ErMorphine Sulfate	15	$371
Tramadol Hcl	33	$337
Tizanidine Hcl	33	$168
Meloxicam	59	$117
Methadone Hcl	11	$69

Paid to pharmacies, not to this prescriber.

Other pain medicine in Skokie

Daniel ChaSkokie$16K
Ricardo VallejoBloomington$2.3M
David DickersonEvanston$558K
Thomas DahlbergRockford$218K
Steven CohenChicago$217K
Albert SinghQuincy$212K
Ryan KutaNaperville$114K
Anthony LebarioElgin$87K
Keith SchmidtHoffman Estates$81K
Jay HurhLibertyville$71K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →